Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02653144 · ClinicalTrials.gov registry record · Phase 4
the Analgesic Duration of Dexmedetomidine Compared to Dexamethasone as Adjuncts to Single Shot Interscalene Block
A Phase 4 study of Opioid Use, Unspecified, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 105
- Enrollment target
- 1
- Study location
NCT02653144 is a Phase 4 study of Opioid Use, Unspecified that has completed, run by Montefiore Medical Center. The registered enrollment target is 105 participants, below the 216-participant average among 9 other Opioid Use, Unspecified trials with a reported enrollment target (51% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02653144, a Phase 4 study of Opioid Use, Unspecified, has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 105 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to determine if perineural dexmedetomidine can provide increased prolongation of analgesia when compared to perineural dexamethasone in patients receiving regional block for shoulder surgery. If so, dexmedetomidine may serve as a superior adjunct to peripheral nerve blocks in a rapidly evolving, ambulatory-centered surgical setting.
Conditions Studied
Interventions
- DRUG Dexamethasone
- DRUG Dexmedetomidine
- DRUG Ropivacaine
Study Locations (1)
New York
- Montefiore Medical Center - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2016-03 |
| Est. Completion | 2018-11-27 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02653144
The ClinicalTrials.gov registry entry for NCT02653144 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 216-participant average among 9 other Opioid Use, Unspecified trials with a reported enrollment target (51% lower). The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Opioid Use, Unspecified appearing as the primary indexed condition, and to 3 interventions - of which Dexamethasone is the first listed.
NCT02653144 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT02653144 about?
NCT02653144 is a clinical study titled "the Analgesic Duration of Dexmedetomidine Compared to Dexamethasone as Adjuncts to Single Shot Interscalene Block". The purpose of the study is to determine if perineural dexmedetomidine can provide increased prolongation of analgesia when compared to perineural dexamethasone in patients receiving regional block for shoulder surgery. If so, dexmedetomidine may serve as a superior adjunct to peripheral nerve block...
What is the current status of trial NCT02653144?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 105 participants. The study started on 2016-03. Estimated completion is 2018-11-27.
What conditions does trial NCT02653144 study?
This clinical trial studies the following conditions: Opioid Use, Unspecified.
What interventions are being tested in trial NCT02653144?
The interventions under investigation include: Dexamethasone (DRUG), Dexmedetomidine (DRUG), Ropivacaine (DRUG).
Who is sponsoring clinical trial NCT02653144?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02653144 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use, Unspecified
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Opioid Use Disorder in Pregnancy in Long-Term Maternal/Infant Outcomes
RECRUITING
-
Sensory Outcomes in Active Substance Users
RECRUITING
-
Patient Utilization of Opioid Destruction Bags in the Post-op Period
ACTIVE NOT RECRUITING · NA
-
Pectoral Nerve Blocks (PECs) for Cardiovascular Implantable Electronic Device Placement
ACTIVE NOT RECRUITING · Phase 2
-
Opioid Modulation and Neural Reward Activation in Healthy Adults
COMPLETED · Phase 1
-
Controlled Substance Treatment Agreements in an Internal Medicine Residents' Clinic
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.